{"id":6965,"date":"2011-10-05T09:26:55","date_gmt":"2011-10-05T14:26:55","guid":{"rendered":"http:\/\/www.heart-valve-surgery.com\/heart-surgery-blog\/?p=6965"},"modified":"2025-05-10T15:34:04","modified_gmt":"2025-05-10T20:34:04","slug":"jena-valve-tavi-ce-aortic-valve-replacement","status":"publish","type":"post","link":"https:\/\/www.heart-valve-surgery.com\/heart-surgery-blog\/2011\/10\/05\/jena-valve-tavi-ce-aortic-valve-replacement\/","title":{"rendered":"JenaValve Gets CE Mark For TAVR Device In Europe"},"content":{"rendered":"

As many patients in the United States have benefitted from the use transcatheter aortic valve replacement (TAVR) devices for the treatment of aortic stenosis, another TAVR technology received a CE mark for commercial use in Europe for aortic regurgitation.<\/p>\n

 <\/p>\n

\"Jena
\nJenaValve TAVR – Aortic Valve Replacement Via Catheter<\/p>\n

 <\/p>\n

<\/p>\n

JenaValve Technology, a medical device manufacturer in Germany, announced its receipt of a CE mark for its 2nd-generation transapical TAVR system. As you may know, this technological breakthrough is used to treat patients with severe aortic regurgitation<\/a>\u00a0who are considered “inoperable” or too “high-risk” for surgery.<\/p>\n

Using the JenaValve, a patient’s diseased aortic valve can be replaced<\/a> without traditional surgical procedures that use incisions to the sternum (sternotomy) or ribs (thoracotomy).<\/p>\n

 <\/p>\n

\"Jena
\nThe JenaValve & Its Delivery System<\/p>\n

 <\/p>\n

Reflecting upon this announcement, Prof. Dr. Friedrich-Wilhelm Mohr, Medical Director of the Department of Cardiac Surgery at the University of Leipzig Heart Center, noted:<\/p>\n

 <\/p>\n

“Now patients have access to a new generation system for transapical TAVR treatment. The JenaValve design allows the cardiac surgeon and cardiologist to achieve precise positioning and allows repositioning of the heart valve prosthesis with its unique, patented positioning feelers. It is with these key features that the system distinguishes itself from its competitors,\u201d — Prof. Mohr.<\/em><\/p><\/blockquote>\n

 <\/p>\n

There are other TAVR devices that are similar to the JenaValve, including the Edwards SAPIEN Valve and the Medtronic Evolut<\/a>. However, those devices are used to treat aortic stenosis not aortic regurgitation.<\/p>\n

Related Links:<\/p>\n